Armin (Armine)

A reversible organophosphorus cholinesterase inhibitor. It also affects the presynaptic membrane and inhibits membrane postsynaptic cholinergic receptors. The compound had former use as a miotic.

Also Known As:

Networked: 24 relevant articles (1 outcomes, 1 trials/studies)

Relationship Network

Bio-Agent Context: Research Results

Experts

1.	Nef, Tobias: 4 articles (01/2011 - 01/2009)
2.	Riener, Robert: 3 articles (01/2015 - 01/2009)
3.	Klamroth-Marganska, Verena: 2 articles (01/2015 - 12/2009)
4.	Brokaw, Elizabeth B: 2 articles (01/2011 - 01/2011)
5.	Lum, Peter S: 2 articles (01/2011 - 01/2011)
6.	Albisser, Urs: 1 article (01/2015)
7.	Curt, Armin: 1 article (01/2015)
8.	Keller, Urs: 1 article (01/2015)
9.	Rudhe, Claudia: 1 article (01/2015)
10.	Schölch, Sabine: 1 article (01/2015)

Related Diseases

1.	Anaphylaxis (Anaphylactic Shock) 03/01/1976 - "The challenging introduction of armine in a dose equalling the sensitizing one produced an anaphylactic shock in a group of animals sensitized with single doses of 0.005 and 0.0005 mg/kg. The allergic nature of these reactions was also confirmed by a large number of positive results secondary to immunological tests preceding the challenging dose, viz. "
2.	Stroke (Strokes) 12/17/2009 - "The objective of this study was to investigate the effects of intensive arm training on motor performance in four chronic stroke patients using the robot ARMin II. ARMin II is an exoskeleton robot with six degrees of freedom (DOF) moving shoulder, elbow and wrist joints. " 01/01/2011 - "To aid in training inter-joint movement coordination a haptic guidance method for functional driven rehabilitation after stroke called Time Independent Functional Training (TIFT) has been developed for the ARMin III robot. " 12/17/2009 - "Effects of intensive arm training with the rehabilitation robot ARMin II in chronic stroke patients: four single-cases." 01/01/2009 - "To test whether intensive arm training with the arm exoskeleton ARMin I is feasible with chronic-stroke patients and whether it improves motor function in the paretic arm. " 01/01/2009 - "Effects of arm training with the robotic device ARMin I in chronic stroke: three single cases."
3.	Poisoning 11/01/1990 - "The data obtained reveal the possible of nonquantal secretion of the mediator from the motor nerve endings of the skeletal muscles in the pathogenesis of acute poisonings with armin." 01/01/1983 - "The preventive action of galanthamine against the armin poisoning does not relate to presynaptic processes." 01/01/1964 - "[PROTECTIVE EFFECT OF SOME CHOLINOLYTICS IN ARMIN POISONING]." 05/01/1963 - "[DEPRESSION OF CHOLINESTERASE ACTIVITY OF ORGANS AND TISSUES IN EXPERIMENTAL ARMINE POISONING]." 11/01/1999 - "[Protection of mice by carbamates cholinesterase inhibitors against poisoning by armin and its dependence on certain physico-chemical indicators]."
4.	Neoplasms (Cancer) 01/01/2011 - "Could TCTP contribute to Armin Braun's paradigm of tumor reversion in plants?" 01/01/2014 - "Armin Braun demonstrated that Agrobacterium infected cells had unusual nutritional properties, and that the bacterium was necessary to start the infection but not for continued tumor development. "
5.	Glaucoma 01/01/1960 - "[Use of armin in glaucoma]." 09/01/1971 - "[Effect of nibuphine, pilocarpine and armine on the size of the blind spot and angioscotoma in patients with primary glaucoma]."

Related Drugs and Biologics

1.	Cholinergic Antagonists (Anticholinergics)
2.	Cholinesterase Inhibitors (Anticholinesterases)
3.	Atropine
4.	Cholinergic Agents (Cholinergics)
5.	Poisons
6.	Pilocarpine (Ocusert)
7.	Physostigmine
8.	Organophosphorus Compounds
9.	Neostigmine (Neostigmine Bromide)
10.	Malathion (Karbofos)

Related Therapies and Procedures

1.	Therapeutics
2.	Exoskeleton Device